OBJECTIVE: This study aimed to investigate the correlation between coronary artery stenosis and Mimecan expression in patients with coronary heart disease (CHD). METHODS: Seventy eight patients with CHD and 80 controls without vascular lesions were recruited into present study. CHD patients were divided into one-vessel CHD subgroup, 2-vessel CHD subgroup and multivessel CHD subgroup. ELISA was performed to detect the expressions of serum Mimecan and nuclear factor kappaB (NF-κB). RESULTS: When compared with control group, the expressions of serum mimecan gene and NF-κB significantly increased in CHD groups (P < 0.05); When compared with one-vessel and two-vessel CHD subgroups, the expressions of serum mimecan and NF-κB significantly increased in multivessel CHD subgroup (P < 0.05), significant difference was observed among three subgroups (P < 0.05). The expressions of serum mimecan and NF-κB were positively related to the severity of coronary lesions (rmimecan=0.79, rNF-κB=0.83, P < 0.05). CONCLUSION: Increased expressions of serum mimecan and NF-κB in CHD patients are related to cardiac insufficiency, which may be ascribed to the binding of NF-κB to mimecan gene.
OBJECTIVE: This study aimed to investigate the correlation between coronary artery stenosis and Mimecan expression in patients with coronary heart disease (CHD). METHODS: Seventy eight patients with CHD and 80 controls without vascular lesions were recruited into present study. CHD patients were divided into one-vessel CHD subgroup, 2-vessel CHD subgroup and multivessel CHD subgroup. ELISA was performed to detect the expressions of serum Mimecan and nuclear factor kappaB (NF-κB). RESULTS: When compared with control group, the expressions of serum mimecan gene and NF-κB significantly increased in CHD groups (P < 0.05); When compared with one-vessel and two-vessel CHD subgroups, the expressions of serum mimecan and NF-κB significantly increased in multivessel CHD subgroup (P < 0.05), significant difference was observed among three subgroups (P < 0.05). The expressions of serum mimecan and NF-κB were positively related to the severity of coronary lesions (rmimecan=0.79, rNF-κB=0.83, P < 0.05). CONCLUSION: Increased expressions of serum mimecan and NF-κB in CHD patients are related to cardiac insufficiency, which may be ascribed to the binding of NF-κB to mimecan gene.
Authors: L Madisen; M Neubauer; G Plowman; D Rosen; P Segarini; J Dasch; A Thompson; J Ziman; H Bentz; A F Purchio Journal: DNA Cell Biol Date: 1990-06 Impact factor: 3.311
Authors: Karen Gabriels; Saske Hoving; Marion J Gijbels; Jeffrey F Pol; Johannes A te Poele; Erik A Biessen; Mat J Daemen; Fiona A Stewart; Sylvia Heeneman Journal: Radiother Oncol Date: 2014-03-11 Impact factor: 6.280
Authors: José Luis Martín-Ventura; Luis Miguel Blanco-Colio; Begoña Muñoz-García; Almudena Gómez-Hernández; Ana Arribas; Luis Ortega; José Tuñón; Jesús Egido Journal: Stroke Date: 2004-01-22 Impact factor: 7.914
Authors: Andreas Kampmann; Borja Fernández; Elisabeth Deindl; Thomas Kubin; Frederic Pipp; Inka Eitenmüller; Imo E Hoefer; Wolfgang Schaper; René Zimmermann Journal: Mol Cell Biochem Date: 2008-11-04 Impact factor: 3.396
Authors: Eiji Matsuura; Fabiola Atzeni; Piercarlo Sarzi-Puttini; Maurizio Turiel; Luis R Lopez; Michael T Nurmohamed Journal: BMC Med Date: 2014-03-18 Impact factor: 8.775